- Home
- UVV vs BBOT Comparison
UVV vs BBOT Comparison
Compare UVV & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UVV | BBOT |
|---|---|---|
| Founded | 1886 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UVV | BBOT |
|---|---|---|
| Price | $52.29 | $13.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.80 |
| AVG Volume (30 Days) | ★ 176.9K | 168.9K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 6.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.44 | N/A |
| Revenue | ★ $2,987,411,000.00 | N/A |
| Revenue This Year | $3.21 | N/A |
| Revenue Next Year | $1.02 | N/A |
| P/E Ratio | $11.77 | ★ N/A |
| Revenue Growth | ★ 3.01 | N/A |
| 52 Week Low | $49.40 | $8.50 |
| 52 Week High | $67.33 | $14.78 |
Technical Indicators
Market Signals| Indicator | UVV | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | N/A |
| Support Level | $52.30 | N/A |
| Resistance Level | $53.25 | N/A |
| Average True Range (ATR) | 0.81 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 23.91 | 0.00 |
Price Performance
Historical ComparisonAbout UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.